ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
|
2024-11-07 8:10:49 AM
|
Chg.
-0.50
|
Volume |
Bid8:10:52 AM |
Ask8:10:52 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
102.10EUR
|
-0.49%
|
0
Turnover: 0.00 |
102.05Bid Size: 50 |
103.05Ask Size: 50 |
20.43 bill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
4.91 USD |
346.36% |
| EPS Diluted: |
4.88 USD |
343.64% |
| Revenues per Share: |
36.05 USD |
8.57% |
| Book Value per Share: |
60.89 USD |
5.81% |
| Cash Flow per Share: |
7.71 USD |
18.84% |
| Dividend per Share: |
0.96 USD |
0.00% |
| Total |
in mill. |
|
| Revenues: |
7,394.20 USD |
6.55% |
| Net Income: |
1,024.00 USD |
342.52% |
| Operating Cash Flow: |
1,581.60 USD |
- |
| Cash and Cash Equivalents: |
415.80 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
22.44 |
24.79 |
| P/S Ratio: |
3.06 |
3.38 |
| P/BV ratio: |
1.81 |
2.00 |
| P/CF Ratio: |
14.29 |
15.78 |
| PEG: |
0.06 |
0.07 |
| Earnings Yield: |
4.46% |
4.03% |
| Dividend Yield: |
0.87% |
0.79% |
| Market Capitalization |
|
| Market Capitalization: |
20.43 bill. EUR |
22.61 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
199.07 mill. |
|
Profitability
| Gross Profit Margin: |
71.82% |
| EBIT Margin: |
17.28% |
| Net Profit Margin: |
13.85% |
| Return on Equity: |
8.20% |
| Return on Assets: |
4.76% |
Financial Strength
| Liquidity I / Cash Ratio: |
0.15% |
| Liquidity II / Quick Ratio: |
0.65% |
| Liquidity III / Current Ratio: |
1.61% |
| Debt / Equity Ratio: |
0.46% |
| Dynam. Debt / Equity Ratio: |
569.60% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
US GAAP |
